Within most human and mouse cancers there is a signifi cant macrophage population, attracted to the tumor microenvironment by cytokines and chemokines such as CSF-1 and CCL2 ( 1, 2 ) . Macrophages are plastic cells; their phenotype depends on their anatomical location and the physiological or pathological context. Classically activated macrophages (also called M1) and " alternatively " activated macrophages (M2) represent two extremes in the spectrum of the macrophage phenotype ( 3 ) . Tumor-associated macrophages (TAMs) closely resemble " alternative " (M2) macrophages ( 4 ) . M2 macrophages produce high amounts of IL-10 but not IL-12, express scavenger receptors, and exhibit antiinfl ammatory and tissue repair functions ( 5 ) . In contrast, M1 macrophages, activated by microbial products or IFN-␥ , produce large amounts of proinfl ammatory cytokines, express high levels of MHC molecules, and are potent killers of pathogens and tumor cells ( 3 ) . Despite their intrinsic antitumor potential as both tumoricidal cells and the major antigen-presenting cells present in tumors, ablation of macrophage function or their infi ltration into experimental tumors inhibits cancer growth and metastasis ( 1, 6, 7 ) . Due to the large TAM population in many tumors, an attractive therapeutic approach would be to increase their tumoricidal activity and attempt to promote antitumor immunity.
Recent studies in mouse models of colon and liver cancer have defi ned an important role for NF-B activation in driving cancer-associated infl ammation ( 8, 9 ) . Our data describe an additional role for NF-B in maintaining the immunosuppressive TAM phenotype. We have previously shown that malignant epithelial cells polarize macrophages to an M2-like phenotype ( 10, 11 ) . Here, we show that malignant epithelial cells drive NF-B activation in TAMs in a way that maintains their immunosuppressive phenotype.
The experiments described here are based on the hypothesis that NF-B signaling is the central mechanism that maintains the alternative phenotype of TAMs. To investigate this we have used two diff erent approaches to block NF-B activity specifi cally in macrophages, both
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and elevated inducible nitric oxide (NO) synthase (NOS2) expression ( Fig. 2 B and Fig. S1 C) . Furthermore, increased NOS2 expression correlated with an increase in NO levels in the co-culture supernatant ( Fig. 2 A and Fig. S1 B) . These data suggested that inhibition of IKK ␤ signaling in BMDMs co-cultured with ID8 cells, and TAMs isolated from established tumors, switched macrophages from an M2 to a " classically " activated M1 phenotype. of which target I B kinase (IKK) ␤ , the major activator of NF-B. Mouse bone marrow -derived macrophages (BMDMs) were infected with a recombinant adenovirus expressing a dominant-negative inhibitor of IKK ␤ (Adv-IKK ␤ DN ). IKK ␤ expression was also targeted in mice harboring a " fl oxed " Ikk ␤ allele (IKK ␤ f/f ) with adenovirus expressing Cre recombinase (Adv-Cre) to generate IKK ␤ -null macrophages (IKK ␤ ⌬ ) ( 12 ) . Our data show that targeting IKK ␤ activity in BMDMs co-cultured with malignant tumor cells or TAMs isolated from established tumors reverses their tumor-promoting activity and promotes an antitumor M1 phenotype.
RESULTS AND DISCUSSION
We previously showed that co-culture of BMDMs with human and mouse ovarian cancer cells led to increased tumor cell invasion ( 10, 11 ) . In the fi rst series of experiments described here, we investigated the macrophage signaling pathways that drive tumor cell invasion using co-cultures of BMDMs and syngeneic ID8 mouse ovarian cancer cells. Our fi rst observation was that co-culture with macrophages defi cient in MyD88 and IL-1R but not Toll-like receptor (TLR)2 or TLR4 inhibited, rather than increased, invasiveness of tumor cells in vitro ( Fig. 1 A ) . Downstream of IL-1R and MyD88, we found that the ability of macrophages to enhance tumor cell invasiveness was dependent on NF-B activation. Specifi c inhibition of IKK ␤ signaling and NF-B activation by expression of IKK ␤ DN or targeted deletion of IKK ␤ (IKK ␤ ⌬ ) in BMDMs prevented these cells from enhancing tumor cell invasiveness in vitro ( Fig. 1 A and Fig. S1 A, which is available at http://www.jem.org/cgi/content/full/jem.20080108/DC1). We also isolated CD11b + TAMs from ID8 tumor-bearing mice and infected them in vitro with Adv-IKK ␤ DN before co-culture with ID8 cells. As with BMDMs, inhibition of IKK ␤ activity in TAMs also prevented tumor cell invasion ( Fig. 1 A ) .
Previous literature has suggested that the mechanism by which inhibition of NF-B prevented macrophage-induced tumor cell invasion might be due to decreased production of chemotactic factors by macrophages ( 8 ) . But in fact we found that co-culture with IKK ␤ -targeted BMDMs or TAMs isolated from established tumors increased tumor cell apoptosis, as measured by caspase 3/7 activation ( Fig. 1 B ) . In addition, inhibition of IKK ␤ activity in BMDMs or TAMs enhanced macrophage-mediated tumoricidal activity in vitro ( Fig. 1 C ) .
We have previously shown that co-culture with ID8 cells polarizes macrophages to an M2-like phenotype: IL-10 high , IL-12 low , increased scavenger receptor expression, and TNF-␣ high ( 10, 11 ) . NF-B inhibition by expression of IKK ␤ DN or targeted deletion of IKK ␤ (IKK ␤ ⌬ ) in BMDMs and TAMs isolated from ID8 tumors reduced production of IL-10 and TNF-␣ upon co-culture with tumor cells in vitro ( Fig. 2 A and Fig. S1 B) ; however, IKK ␤ inhibition increased production of the antitumor cytokine IL-12 ( Fig. 2 A and Fig. S1 B) . The IL-12 high IL-10 low phenotype of IKK ␤ -targeted macrophages was associated with decreased expression of arginase-1 As Stat1 is an essential transcription factor for IL-12, MHC class II, and NOS2 expression ( 13 ), we analyzed Stat1 activation in macrophages co-cultured with tumor cells. When IKK ␤ -targeted macrophages were co-cultured with ID8 tumor cells, they showed increased tyrosine phosphorylation of Stat1 (pY-Stat1, Tyr701), which correlated with increased NOS2 expression ( Fig. 2 C ) . NOS2 has been directly implicated in macrophage-mediated tumoricidal activity ( 14 ) , and several in vitro studies have demonstrated that NO donors are cytotoxic and proapoptotic to tumor cells ( 15, 16 ) . We performed 111 In-release cytotoxicity assays in the presence of a selective NOS2 inhibitor, 1400W, and demonstrated that inhibition of NOS2 rescues the cytotoxic activity of IKK ␤ -targeted BMDMs or TAMs isolated from established tumors ( Fig. 2 D and Fig. S1 D) . These data suggest that IKK ␤ -mediated suppression of Stat1 activation inhibits the M1 phenotype and tumoricidal activity of tumor-polarized macrophages.
To investigate the in vivo implications of these observations, we adoptively transferred IKK ␤ -targeted macrophages into mice bearing established ovarian tumors to test if " re-educating " macrophages through IKK ␤ inhibition could aff ect tumor progression. ID8 ovarian cancer cells that expressed fi refl y luciferase were injected i.p. into mice. After 5 wk, these mice had malignant ascites and established tumors, with deposits throughout the peritoneum ( which is available at http://www.jem.org/cgi/content/full/ jem.20080108/DC1) in ascites from mice adoptively transferred with IKK ␤ -targeted macrophages. We therefore reasoned that an IL-12 -mediated increase in NK cells in the peritoneum may contribute to the tumoricidal eff ect of targeting IKK ␤ in TAMs. To investigate this hypothesis, we treated mice with a neutralizing IL-12p40 antibody before adoptive transfer of macrophages. Neutralizing IL-12 in our model rescued the increased recruitment of NK cells in mice receiving IKK ␤ -targeted macrophages and restored tumor growth to similar levels as in controls ( Fig. 5 , A -C , and Fig. S3 ). The p40 subunit of IL-12 is shared with the related proinfl ammatory cytokine IL-23 ( 17 ) . To rule out a role for IL-23, we used a neutralizing antibody against IL-23p19. Fig. S2 ). These data show that targeting IKK ␤ activity in BMDMs prevents their polarization to an M2 phenotype by the tumor microenvironment in vivo. In addition, we show that inhibition of IKK ␤ in TAMs isolated from established tumors switches their phenotype from tumor-promoting M2 to antitumor M1.
Despite a sustained antitumor eff ect upon transfer of IKK ␤ -targeted macrophages in vivo, there was only a transient increase in NO production. This suggested that a different mechanism might be responsible for the long-term inhibition of tumor growth. Of particular interest was a signifi cant (P < 0.01) increase in NK cells ( Fig. 5 A and Fig. S3 , mediator of NF-B activation in our co-culture system. To investigate the role of IL-1R/MyD88 signaling in macrophage polarization in vivo, we adoptively transferred BMDMs defi cient in MyD88, TLR2, TLR4, or IL-1R into ID8 tumor -bearing mice. Mice treated with IL-1R Ϫ / Ϫ or MyD88 Ϫ / Ϫ macrophages had signifi cantly less tumor burden after 14 d (S4A). In addition, ascitic fl uid from mice treated with IL-1R Ϫ / Ϫ or MyD88 Ϫ / Ϫ macrophages contained lower levels of IL-10 but higher levels of IL-12p70 compared with control groups (S4B). A similar switch toward an M1 phenotype was observed in the resident ascitic CD11b + population with an IL-12p40 high arginase-1 low expression profi le (S4C).
In summary, these data show that inhibition of IKK ␤ activity specifi cally in TAMs is able to reverse their tumorpolarized phenotype and re-educate them to actively kill tumor cells by both direct tumoricidal activity through NO Neutralizing IL-23p19 had no eff ect on tumor growth ( Fig. 5 C  and Fig. S3) . In further experiments, we recapitulated NK cell -mediated tumoricidal activity ex vivo using purifi ed spleen NK cells. DX5 + NK cells were isolated and treated with ascitic fl uid from the adoptive transfer experiments described above. When NK cells were stimulated with ascites from mice receiving IKK ␤ -targeted macrophages, they showed a significant increase in tumoricidal activity ( Fig. 5 D and Fig. S3 ). This increase in cytotoxicity was rescued with a neutralizing antibody to IL-12p40, whereas neutralizing IL-23p19 had an additive eff ect ( Fig. 5 D and Fig. S3) .
The data described above show that IKK ␤ signaling in macrophages maintains their alternative tumor-promoting phenotype. The experiments described in Fig. 1 show that IL-1R/MyD88 signaling in macrophages is important in driving tumor cell invasion, suggesting that IL-1 may be the soluble characterized by high expression of IL-10, TNF-␣ , and arginase-1, but low NOS2, IL-12, and MHC II expression. There is a large macrophage population in many tumors, and our data suggest that we may be able to harness their intrinsic antitumor potential to promote tumor regression. During the 1990s there were clinical trials of in vitro -activated autologous macrophages, using either IFN-␥ alone or in combination with LPS; however, this approach had only limited success ( 18, 19 ) . We have shown convincingly that targeting IKK ␤ in TAMs reverses their tumor-promoting activity and can drive tumor regression in vivo. These studies suggest that IKK ␤ inhibitors could represent a powerful therapeutic tool in cancer therapy. Besides the direct eff ects on antiapoptotic signaling in malignant cells, IKK ␤ inhibition may also modify the infl ammatory microenvironment to promote an antitumor immune response.
MATERIALS AND METHODS
Cell lines and reagents. The mouse ovarian cancer cell line ID8 (provided by K. Roby, University of Kansas, Kansas City, KS) ( 20 ) was cultured as described previously ( 10 ) . Lentiviral infection of ID8 cells with luciferase reporter construct was performed as described previously ( 21 ) . In vitro luciferase activity was assayed in 0.5 × 10 6 ID8 cells in triplicate and according to the manufacturer ' s instructions (Promega). ID8 -macrophage co-cultures were performed as described previously ( 22 ) . production and the promotion of NK cell -mediated antitumor immunity through IL-12.
The studies described above reveal a new role for IKK ␤ in cancer-related infl ammation. We demonstrate a previously unknown function for IKK ␤ in maintaining the alternative phenotype of TAMs and negative regulation of macrophage tumoricidal activity. In malignant disease, macrophages are recruited to the tumor from the circulation and become polarized to an alternative immunosuppressive phenotype, Bioluminescence imaging. Tumor progression was assessed in situ by bioluminescent imaging as described previously ( 21 ) .
Flow cytometry. The phenotype of transferred macrophages was assessed by FACS analysis on a FACScan fl ow cytometer and analyzed using Cellquest software (Becton Dickinson).
Cytotoxicity assays. For 111 In-release assay, a cytotoxicity assay was performed for 24 h with macrophages. Radioactivity was measured by counting 1 min in a ␥ counter. For 51 Cr-release assays, NK cell cytotoxicity was defi ned as lysis of target cells after 4 h. Ascite samples from tumor-bearing mice treated with adoptive transfer of modifi ed macrophages were concentrated under vacuum for 30 min at 37 ° C. In vitro stimulation with ascites was performed by adding 10 μ g/ml concentrated total ascites at the start of the 4-h cytotoxicity assay. Neutralizing antibodies against IL-12p40/70 (17.8; R & D Systems) or IL-23p19 (G23-8; eBioscience) or the respective control antibody were added to the release assay at 10 μ g/ml.
The percentage of cytotoxic activity was calculated as the specifi c release of radioactivity: % cytotoxicity = [(experimental isotope Ϫ spontaneous isotope)/total isotope Ϫ spontaneous isotope)] × 100.
ELISA-based assays. To determine caspase-3/7 activity (Promega), cytokine levels in cell culture supernatant or ascite ELISAs (R & D Systems) were used according to the manufacturer ' s instructions.
Statistical analysis.
Experiments were performed in triplicate, and representative data are shown. Results were tested for statistical signifi cance using Student ' s t test with Welch ' s correction or the Mann-Whitney test with GraphPad Prism Version 4.0c software.
Online supplemental material. Fig. S1 shows the results of the NF-B activity assay, the in vitro profi le for in vivo -generated TAMs under coculture. Fig. S2 summarizes the in vivo adoptive transfer of IKK ␤ ⌬ macrophages and their respective controls. Fig. S3 shows the eff ect of neutralizing IL12p40 and IL-23p19, and NK cell data. Fig. S4 shows ex vivo analysis of tumor burden in mice adoptively transferred with macrophages from MyD88, TLR2, TLR4, and IL-1R knockout mice. The online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20080108/DC1.
